TotalMarketCap

Lipocine

LPCNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$12.572 M

$1.53 +5.90%

Close of 6 Nov 2026

As of 6 Nov 2026, Lipocine (LPCN) has a market capitalization of $12.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.98M

#3400 by revenue

Earnings

-$9.63M

Loss-making

Shares outstanding

11,073,439

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #400Optimi HealthOPTH$13.5M
  2. #401Radiopharm TheranosticsRADX$12.9M
  3. #402LipocineLPCN$12.6M
  4. #403Bolt BiotherapeuticsBOLT$12.6M
  5. #404Dare BioscienceDARE$12.3M

What if Lipocine were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,425,037

Per share 2,245,926× higher

Bitcoin $1.53T

$185,322.80

Per share 121,523× higher

Apple $5.02T

$608,397.46

Per share 398,949× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Lipocine are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.